Skip to main content

Advertisement

Log in

Assessment of preoperative hypercoagulability in patients with pancreatic ductal adenocarcinoma (PDAC) using rapid thromboelastography (r-TEG)

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

Patients with malignant tumors are usually accompanied with hypercoagulability state and high incidence risk of venous thromboembolism (VTE), especially in patients with pancreatic ductal adenocarcinoma (PDAC). However, conventional coagulation test is failed to identify this abnormity. We retrospectively reviewed clinical data of 78 PDAC patients and 79 age-matched controls with rapid thromboelastography (r-TEG) and conventional coagulation test. The main index of r-TEG include TEG-ACT (second), R (second), K (second), angleα (°) and MA (mm), and a short TEG-ACT, short R, a short K, a broad angleα and a prolonged MA can identify hypercoagulability. Compared with age-matched controls, the PADC patients were analyzed to have a shorter K value (72. + 24 ± 22.90 vs. 85.63 ± 32.81, P = 0.0014), increased angleα value (76.20 ± 3.68 vs. 74.415 ± 4.73, P = 0.009) and MA value (63.33 ± 7.19 vs. 60.89 ± 5.52, P = 0.18). Both TEG-ACT (101.72 ± 7.57 vs. 103.78 ± 7.33, P = 0.086) and R (32.95 ± 4.72 vs. 34.34 ± 4.61, P = 0.085) value showed no significant difference in two groups. The laboratory values for conventional coagulation test were within normal ranges: PT (11.65 ± 0.95 vs. 11.38 ± 0.79, P = 0.049), INR (1.01 ± 0.09 vs. 0.98 ± 0.08, P = 0.101), aPTT (28.75 ± 3.45 vs. 28.00 ± 2.98, P = 0.149) and TT (19.44 ± 1.12 vs. 19.69 ± 1.35, P = 0.212). Incidence rates of VTE were 3.8% (3 of 78 patients) and 1.3% (1 of 79 patients) respectively (Fisher’s exact test: P = 0.367). Several r-TEG indexes can indicate coagulation disorders within PDAC patients, but the incidence rates of VTE for both PDAC patients and normal controls had no significant difference. Compare to the control group, the potential hypercoagulability of PDAC patients did not correlate to thrombotic complications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Heit JA et al (2002) Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med 162(11):1245–1248

    Article  Google Scholar 

  2. Khorana AA (2003) Malignancy, thrombosis and Trousseau: the case for an eponym. J Thromb Haemost 1(12):2463–2465

    Article  CAS  Google Scholar 

  3. Ansari D et al (2015) Pancreatic cancer and thromboembolic disease 150 years after Trousseau. Hepatobiliary Surg Nutr 4(5):325–335

    PubMed  PubMed Central  Google Scholar 

  4. Toukh M et al (2014) Thromboelastography identifies hypercoagulablilty and predicts thromboembolic complications in patients with prostate cancer. Thromb Res 133(1):88–95

    Article  CAS  Google Scholar 

  5. Siegel RL, Miller KD, Jemal A (2017) Cancer statistics, 2017. CA Cancer J Clin 67(1):7–30

    Article  Google Scholar 

  6. Kessler CM (2009) The link between cancer and venous thromboembolism: a review. Am J Clin Oncol 32(4):S3–S7

    Article  Google Scholar 

  7. Chew HK et al (2006) Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med 166(4):458–464

    Article  Google Scholar 

  8. Khorana AA, Fine RL (2004) Pancreatic cancer and thromboembolic disease. Lancet Oncol 5(11):655–663

    Article  CAS  Google Scholar 

  9. Mandala M et al (2007) Venous thromboembolism predicts poor prognosis in irresectable pancreaticcancer patients. Ann Oncol 18(10):1660–1665

    Article  CAS  Google Scholar 

  10. Pannucci CJ et al (2011) Validation of the caprini risk assessment model in plastic and reconstructive surgery patients. J Vasc Surg 212(1):105–112

    Google Scholar 

  11. Bahl V et al (2010) A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg 251(2):344

    Article  Google Scholar 

  12. Falck-Ytter Y et al (2012) Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis: American college of chest physicians evidence-based Clinical practice guidelines. Chest 141(2):e278S

    Article  CAS  Google Scholar 

  13. Grant PJ et al (2016) Assessing the caprini score for risk assessment of venous thromboembolismin hospitalized medical patients. Am J Med 129(5):528–535

    Article  Google Scholar 

  14. Liu X et al (2016) Comparison between Caprini and Padua risk assessment models for hospitalized medical patients at risk for venous thromboembolism: a retrospective study. Interact Cardiovasc Thorac Surg 23(4):ivw158

    Google Scholar 

  15. Zakai NA, Wright J, Cushman M (2004) Risk factors for venous thrombosis in medical inpatients: validation of a thrombosis risk score. J Thromb Haemost 2(12):2156–2161

    Article  CAS  Google Scholar 

  16. Wilson D et al (2001) Changes in coagulability as measured by thrombelastography following surgery for proximal femoral fracture. Inj-Int J Care Inj 32(10):765–770

    Article  CAS  Google Scholar 

  17. Wehrum MJ et al (2010) Comparative assessment of hypercoagulability in women with and without gynecologic malignancies using the thromboelastograph coagulation analyzer. Blood Coagul Fibrinolysis 21(2):140–143

    Article  CAS  Google Scholar 

  18. Akay OM et al (2009) Laboratory investigation of hypercoagulability in cancer patients using rotation thrombelastography. Med Oncol 26(3):358–364

    Article  Google Scholar 

  19. Kashuk JL et al (2009) Rapid thrombelastography (r-TEG) identifies hypercoagulability and predicts thromboembolic events in surgical patients. Surgery 146(4):764–774

    Article  Google Scholar 

  20. Levy JH et al (2010) Multidisciplinary approach to the challenge of hemostasis. Anesth Analg 110(2):354

    Article  Google Scholar 

  21. Boccaccio C, Comoglio PM (2009) Genetic link between cancer and thrombosis. J Clin Oncol 27(29):4827–4833

    Article  CAS  Google Scholar 

  22. Khorana AA et al (2007) Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer. Clin Cancer Res 13(10):2870–2875

    Article  CAS  Google Scholar 

  23. Poruk KE et al (2010) Serum platelet factor 4 is an independent predictor of survival and venous thromboembolism in patients with pancreatic adenocarcinoma. Cancer Epidemiol Biomark Prev 19(10):2605–2610

    Article  CAS  Google Scholar 

  24. Shao B et al (2011) Carcinoma mucins trigger reciprocal activation of platelets and neutrophils in a murine model of Trousseau syndrome. Blood 118(15):4015–4023

    Article  CAS  Google Scholar 

  25. Wahrenbrock M et al (2003) Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas. J Clin Invest 112(6):853–862

    Article  CAS  Google Scholar 

  26. McCrath DJ et al (2005) Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction. Anesth Analg 100(6):1576–1583

    Article  Google Scholar 

  27. Hidalgo M (2010) Pancreatic cancer. N Engl J Med 362(17):1605–1617

    Article  CAS  Google Scholar 

  28. Lassen Kristoffer (2013) Guidelines for perioperative care for pancreaticoduodenectomy: enhanced recovery after surgery (ERAS) society recommendations. World J Surg 37:240–258

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bole Tian.

Ethics declarations

Conflict of interest

All of the authors involved in this research declare that they have no conflict of interest.

Ethical approval

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mou, Y., Li, M., Hou, S. et al. Assessment of preoperative hypercoagulability in patients with pancreatic ductal adenocarcinoma (PDAC) using rapid thromboelastography (r-TEG). J Thromb Thrombolysis 48, 648–652 (2019). https://doi.org/10.1007/s11239-019-01908-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-019-01908-8

Keywords

Navigation